Regulatory T-cell frequency and function in acute myocardial infarction patients and its correlation with ventricular dysfunction
- PMID: 38386899
- PMCID: PMC11097913
- DOI: 10.1093/cei/uxae014
Regulatory T-cell frequency and function in acute myocardial infarction patients and its correlation with ventricular dysfunction
Abstract
A high percentage of patients with acute coronary syndrome develop heart failure due to the ischemic event. Regulatory T (Treg) cells are lymphocytes with suppressive capacity that control the immune response and include the conventional CD4+ CD25hi Foxp3+ cells and the CD4+ CD25var CD69+ LAP+ Foxp3- IL-10+ cells. No human follow-up studies focus on Treg cells' behavior after infarction and their possible relationship with ventricular function as a sign of postischemic cardiac remodeling. This study aimed to analyze, by flow cytometry, the circulating levels of CD69+ Treg cells and CD4+ CD25hi Foxp3+ cells, their IL-10+ production as well as their function in patients with acute myocardial infarction (AMI), and its possible relation with ventricular dysfunction. We found a significant difference in the percentage of CD4+ CD25hi Foxp3+ cells and IL-10+ MFI in patients with AMI at 72 hours compared with the healthy control group, and the levels of these cells were reduced 6 months post-AMI. Regarding the suppressive function of CD4+ CD25+ regulatory cells, they were dysfunctional at 3 and 6 months post-AMI. The frequency of CD69+ Treg cells was similar between patients with AMI at 72 hours postinfarction and the control groups. Moreover, the frequency of CD69+ Treg cells at 3 and 6 months postischemic event did not vary over time. Treg cells play a role in regulating inflammation after an AMI, and its function may be compromised in this pathology. This work is the first report to evaluate CD69+ Foxp3- Treg cells in AMI patients.
Keywords: CD69; acute myocardial infarction; inflammation; regulatory T cell.
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Similar articles
-
CD4+CD69+ T cells and CD4+CD25+FoxP3+ Treg cells imbalance in peripheral blood, spleen and peritoneal lavage from pristane-induced systemic lupus erythematosus (SLE) mice.Adv Rheumatol. 2019 Jul 24;59(1):30. doi: 10.1186/s42358-019-0072-x. Adv Rheumatol. 2019. PMID: 31340848
-
Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.J Transl Med. 2015 May 7;13:145. doi: 10.1186/s12967-015-0507-z. J Transl Med. 2015. PMID: 25948100 Free PMC article.
-
Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69+ T Regulatory Cells.Mediators Inflamm. 2017;2017:2513829. doi: 10.1155/2017/2513829. Epub 2017 Sep 6. Mediators Inflamm. 2017. PMID: 29038617 Free PMC article.
-
CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.J Immunol. 2009 Jan 1;182(1):111-20. doi: 10.4049/jimmunol.182.1.111. J Immunol. 2009. PMID: 19109141
-
Regulatory T cells as a therapeutic target in acute myocardial infarction.Mol Immunol. 2024 Aug;172:17-22. doi: 10.1016/j.molimm.2024.06.003. Epub 2024 Jun 11. Mol Immunol. 2024. PMID: 38865800 Review.
References
-
- World Health Organization. Cardiovascular diseases (CVDs). 2021. https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials